K. Jacobsen

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial.

S. Opal, D. Yealy, J. Decruyenaere, 2019, JAMA.

Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial.

D. Angus, D. Yealy, R. Lewis, 2018, Annals of the American Thoracic Society.